Haemonetics Corporation HAE
$102.84
-0.08%
at last close
Financials (TTM)
- Revenue
- $1.35 billion
- Net Income
- $96.29 million
- Net Margin
- 7.12%
- Return on Equity
- 11.50%
- Debt-to-Equity
- 1.42
- P/E Ratio
- 49.68
- Price / Book
- 5.59
- Price / Sales
- 3.46
Over the trailing twelve months, Haemonetics Corporation generated revenue of $1.35 billion and net income of $96.29 million, a net margin of 7.12%.
At the last closing price of $102.84, HAE trades at 49.68 times trailing earnings and 3.46 times sales, with a market capitalization of $4.68 billion.
Key Stats
- Last Close
- $102.84
- Market Cap
- $4.68 billion
- 52-Week Range
- $47.31 – $109.57
- Average Volume
- 807K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.